PARADISI, FRANCO
 Distribuzione geografica
Continente #
NA - Nord America 12.169
EU - Europa 10.637
AS - Asia 4.246
SA - Sud America 606
OC - Oceania 139
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 29
AN - Antartide 1
Totale 27.930
Nazione #
US - Stati Uniti d'America 11.971
PL - Polonia 3.297
RU - Federazione Russa 2.221
IT - Italia 1.863
SG - Singapore 1.126
HK - Hong Kong 791
UA - Ucraina 751
CN - Cina 698
IE - Irlanda 600
DE - Germania 551
SE - Svezia 546
VN - Vietnam 532
KR - Corea 484
BR - Brasile 462
FI - Finlandia 294
FR - Francia 256
IN - India 162
GB - Regno Unito 151
CA - Canada 137
AU - Australia 136
BD - Bangladesh 69
TR - Turchia 61
JP - Giappone 60
AR - Argentina 47
ID - Indonesia 45
SC - Seychelles 39
IQ - Iraq 36
JO - Giordania 27
CO - Colombia 23
MX - Messico 21
TH - Thailandia 21
ZA - Sudafrica 19
BG - Bulgaria 18
EC - Ecuador 18
NL - Olanda 18
BO - Bolivia 14
PK - Pakistan 13
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
SA - Arabia Saudita 11
MA - Marocco 10
PH - Filippine 10
PY - Paraguay 10
AT - Austria 9
CL - Cile 9
NP - Nepal 9
UZ - Uzbekistan 9
ES - Italia 8
NG - Nigeria 8
AL - Albania 7
AZ - Azerbaigian 7
IL - Israele 7
IR - Iran 7
MY - Malesia 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
CZ - Repubblica Ceca 6
LT - Lituania 6
PT - Portogallo 6
CH - Svizzera 5
CR - Costa Rica 5
DZ - Algeria 5
KE - Kenya 5
KZ - Kazakistan 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EG - Egitto 4
LB - Libano 4
NI - Nicaragua 4
OM - Oman 4
PE - Perù 4
RO - Romania 4
TN - Tunisia 4
BE - Belgio 3
BH - Bahrain 3
CI - Costa d'Avorio 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
NZ - Nuova Zelanda 3
BB - Barbados 2
BS - Bahamas 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
MM - Myanmar 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AQ - Antartide 1
AW - Aruba 1
EU - Europa 1
Totale 27.884
Città #
Warsaw 3.294
Santa Clara 2.315
Jacksonville 1.139
Singapore 720
Chandler 701
Dublin 600
Hong Kong 598
Ashburn 542
Fairfield 540
San Jose 469
Milan 464
Seoul 464
Wilmington 299
Council Bluffs 284
Los Angeles 282
Cambridge 275
Woodbridge 243
The Dalles 229
Boardman 220
Princeton 213
Houston 204
Buffalo 197
Rome 195
Lauterbourg 180
Boston 177
Beijing 176
Seattle 168
New York 161
Hanoi 135
Ho Chi Minh City 128
Melbourne 126
Phoenix 119
Hefei 110
Mumbai 110
Dallas 108
Columbus 92
Moscow 90
Ann Arbor 89
Medford 87
Altamura 78
Lawrence 77
Helsinki 68
Naples 61
San Diego 52
Munich 50
Tokyo 50
Dong Ket 49
Auburn Hills 46
Florence 45
Frankfurt Am Main 44
Toronto 44
Izmir 41
Norwalk 41
Turin 41
Verona 40
São Paulo 39
Bologna 38
Chicago 34
Hillsboro 32
Palermo 32
Figino 30
Kent 27
Andover 26
Orem 26
Belo Horizonte 25
Jakarta 25
Atlanta 24
Genoa 24
Catania 23
Denver 23
Haiphong 23
San Francisco 23
Shanghai 22
Brooklyn 21
Rio de Janeiro 21
Brescia 20
London 19
Da Nang 18
Dearborn 18
Montreal 18
Bari 17
Frankfurt am Main 17
Sofia 17
Bangkok 16
Bremen 14
Yubileyny 14
Baghdad 13
Modena 12
Seongnam 12
Turku 12
Austin 11
Dhaka 11
Redwood City 11
San Mateo 11
Venice 11
Brasília 10
Chennai 10
Guangzhou 10
Hải Dương 10
Johannesburg 9
Totale 18.249
Nome #
Nuove prospettive terapeutiche: fra presente e futuro 943
Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics 414
Antibiotic resistance in community-acquired pulmonary pathogens 320
Effect of antibiotic pretreatment on resistance 304
Is Streptococcus pneumoniae a nosocomially acquired pathogen? 304
Antimicrobial resistance in an intensive care unit before adopting an antibiotic rotation programme for empiric therapy of ventilator-associated pneumonia 303
Skeletal tuberculosis and other granulomatous infections 303
Which prophylactic regimen for which surgical procedure? 295
Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains 294
Urinary tract infections in the city of Florence: epidemiological considerations over a twenty-year period 286
Atassia cerebellare acuta in corso di mononucleosi infettiva 283
Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections 281
Terapia antibiotica delle polmoniti nosocomiali 278
Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic 275
Invasive Streptococcus pyogenes infection in a surgeon after an occupational exposure 274
Ciprofloxacin resistance in clinical isolates of Pseudomonas aeruginosa from Italian patients 273
Ruolo del linezolid nella terapia delle infezioni causate da cocchi gram-positivi multiresistenti 266
Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia 263
Infections in multiple myeloma 262
La terapia delle infezioni fungine invasive: dubbi e certezze 257
Toscana virus, a “Mediterranean” agent of aseptic meningitis: analysis of 42 consecutive cases 256
Nuove prospettive terapeutiche nel trattamento delle infezioni in comunità 248
Penetrazione degli antibiotici in distretti speciali 247
Terapia delle infezioni intra-addominali complicate: qualcosa è cambiato nel nostro orizzonte terapeutico? 243
Pathogenetic mechanisms responsible for the production of secondary immunodeficiency 237
Treatment of otitis media 233
Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications. 232
Seroepidemiological study of HIV antibody prevalence in the Santa Cruz region (Bolivia) 192
In vitro antibacterial activity of imipenem and other agents against Gram-negative and Gram-positive strains isolated from clinical specimens 191
Epidemiology of pneumococcal resistance in Florence: much more erythromycin-nonsusceptible (ENSP) than penicillin-nonsusceptible (PNSP) strains 189
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 186
Meropenem versus imipenem/cilastatin in the hospital treatment of community-acquired pneumonia 184
A neuroepidemiological survey in rural Bolivia: background and methods. 181
Incidence of penicillin- (PNSP) and erythromycin- (ENSP) nonsusceptible pneumococci in Florence, Italy, 1992-1999 178
Prevalence of leptospiral infections in humans in Cordillera Province, Bolivia. 178
Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units: a 2-year comparison. 177
Lumbar pain in a married couple who likes cheese: brucella strikes again! 173
Evaluation of a rapid immunochromatographic test for serologic diagnosis of tuberculosis in Italy 172
High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption 169
Molecular alterations of VanA element in vancomycin-resistant enterococci isolated during a survey of colonized patients in an Italian intensive care unit. 166
Absence of HIV infection in low- and high-risk groups in the Santa Cruz region, Bolivia. 165
Antimicrobial resistance (AR) among respiratory pathogens (RP): a unique epidemiology in Italy 165
Post-traumatic infection of the lower limb caused by rare Enterobacteriaceae and Mucorales in a young healthy male 162
Attività comparativa in vitro di meropenem, nuova molecola carbapenemica, nei confronti di batteri gram-positivi e gram-negativi 158
Cefepime 156
Severe head and neck infections in the critical care unit 154
Interactions between antibiotics and immune system 153
Alternative antibiotics for methicillin-resistant (MR) staphylococcal skin lesions in at-risk patients: preliminary results of a surveillance programme in Florence, Italy 150
Resistenza a ciprofloxacin di stafilococchi coagulasi-negativi meticillino-resistenti isolati nell'area fiorentina 149
Attività comparativa in vitro di MDL 62873 nei confronti di microrganismi gram-positivi 149
Antimicrobial agent susceptibility patterns of staphylococci isolated in urban and rural areas of Bolivia 149
Serological survey of toxoplasmosis in the Santa Cruz region of Bolivia. 149
Considerazioni farmacoeconomiche sulla terapia antibiotica delle infezioni osteo-articolari 149
Approccio terapeutico alle infezioni nosocomiali 148
High-level aminoglycoside resistance among enterococci isolated from blood cultures. 147
Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. 147
Acquired immunodeficiency 146
Prevalence of epilepsy in rural Bolivia: a door-to-door survey. 145
Parasitological observations on three Bolivian localities including rural communities, cities and institutions. 145
Antibodies against Trichinella spiralis in the rural population of the Province of Cordillera, Bolivia] 143
Secondary immunodeficiency 142
Effect of a new fluorinated quinolone (ofloxacin) on the chemiluminescence of phagocytosing human neutrophils. 140
Proposal of an improved score method for the diagnosis of pulmonary tuberculosis in childhood in developing countries. 139
High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption 138
In vitro activity of MDL 62,879 against Gram-positive bacteria and bacteroides species 137
An Italian study on the ciprofloxacin activity against clinical isolates of Pseudomonas aeruginosa 137
Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia. 137
The influence of ofloxacin versus trimethoprim-sulfamethoxazole on the aerobic flora in granulocytopenic subjects. 136
Is Streptococcus pneumoniae a nosocomially-acquired pathogen? 135
Treatment of multidrug-resistant tuberculosis 135
Le resistenze batteriche mediate da beta-lattamasi a spettro esteso: conseguenze terapeutiche 134
Population movements and cholera spread in Cordillera Province, Santa Cruz Department, Bolivia. 133
Antibiotic resistance of Enterobacteriaceae isolated from the urinary tract 132
Intestinal parasites in the Camiri, Gutierrez and Boyuibe areas, Santa Cruz Department, Bolivia. 128
Antibiotic susceptibility of urinary pathogens isolated from hospital practice specimens in the Florence area 128
Antibiotic therapy of bacterial meningitis 125
Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. 124
Lo stafilococco meticillino-resistente: una realtà importante nell’attuale panorama della patologia infettiva 122
Utilizzo dei carbapenemici nella terapia delle infezioni intraddominali 122
Seroepidemiological study of HIV antibody prevalence in the Santa Cruz region, Bolivia. 122
Comparative in-vitro activity of MDL 62873 against aerobic and anaerobic gram-positive bacteria 122
Mixed infection of the lower limb caused by rare bacterial and fungal pathogens in a patient with multiple traumatic injuries 122
Urosepsis in the critical care unit. 122
Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south-eastern Bolivia. 120
Different broth dilution procedures generate different apparent MICs for ramoplanin 120
Terapia delle infezioni batteriche delle vie respiratorie inferiori nell'anziano 119
The link between use of antibiotics and acquisition of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and ciprofloxacin-resistant Pseudomonas aeruginosa (CR-PA) in a cohort of 864 patients 119
L'impiego dei fluorochinoloni nelle infezioni diverse da quelle respiratorie ed urinarie 117
Incidence of glycopeptide-resistant enterococci and use of glycopeptides in a Florence hospital 115
Attività in vitro di MDL 62,879 nei confronti di isolati clinici di E.faecalis con e senza resistenza ad altri livelli di aminoglucosidi 115
La mononucleosi infezione degli anni verdi 112
Bacterial infections of the gastrointestinal tract in HIV-infected patients 111
Pneumococco penicillino- ed eritromicino-insensibile nell’area fiorentina: una realtà epidemiologica in mutamento? 110
Multicenter randomised trial comparing meropenem and imipenem cilastatin in the hospital treatment of community acquired pneumonia 110
Terapia delle infezioni streptococciche 109
Le infezioni nosocomiali delle vie urinarie nell'area fiorentina 108
Efficacia clinica di tazobactam/piperacillina nelle infezioni nosocomiali 108
Rilevanza clinica delle sub-MIC degli antibiotici 107
Resistenze batteriche tra gli agenti responsabili di infezioni delle vie aeree superiori 105
Su due casi di mononucleosi infettiva a decorso atipico 105
Totale 18.461
Categoria #
all - tutte 70.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022846 0 0 9 89 21 24 28 73 24 25 269 284
2022/20232.708 318 227 67 250 306 643 255 154 311 38 109 30
2023/2024892 69 139 224 102 52 79 17 153 2 12 28 15
2024/20256.308 221 733 371 926 1.845 943 62 222 505 158 167 155
2025/20267.104 704 914 354 359 555 244 849 401 337 339 827 1.221
2026/20271.291 195 387 709 0 0 0 0 0 0 0 0 0
Totale 27.930